Global Acute Myeloid Leukemia Market Size, Status and Forecast 2021-2027

  • Published Date : 06-09-2021
  • Pages : 98
  • Report Id : 54478
  • Categories : Healthcare

This report focuses on the global Acute Myeloid Leukemia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Myeloid Leukemia development in United States, Europe and China.

Leukemia are a heterogeneous group of cancers affecting the bone marrow and White Blood Cells (WBC). Leukemia is characterized by the rapid increase of abnormal blood cells growth or blasts, resulting in a decrease in the numbers of healthy, normal fully modified blood cells, leading to the typical symptoms of bleeding, anemia, and high risk of infection. 
Primary drivers boosting the growth of acute myeloid leukemia (AML) therapeutics market are minimal but increased prevalence of acute myeloid leukemia (AML), increased drug approval rate for AML, classification of acute myeloid leukemia (AML) as an orphan disease. Over the forecast period, population of people over 65 year is anticipated to increase, which is another key driver for acute myeloid leukemia (AML) therapeutics market.
North America is anticipated to be major contributor to this market accounting maximum percent of share in AML therapeutics market followed by Europe. Slow but constant growth in prevalence for AML in North America is anticipated to fuel the growth in acute myeloid leukemia (AML) therapeutics market. In Asia pacific region, China and India are anticipated to show high growth in acute myeloid leukemia (AML) therapeutics market due to new developments in healthcare infrastructure in the region.
In 2020, the global Acute Myeloid Leukemia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.

The key players covered in this study
Celgene Corporation
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals
Abbvie
Astellas Pharma
CTI Biopharma Corp

Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Stem Cell Transplant
Targeted Therapy
Others

Market segment by Application, split into
Hospital
Retails Drug Stores
Ambulatory Care Centers
Oncology Centers
Clinics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Acute Myeloid Leukemia status, future forecast, growth opportunity, key market and key players.
To present the Acute Myeloid Leukemia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Acute Myeloid Leukemia are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
End of Summary


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Myeloid Leukemia Market Size Growth Rate by Type (2016-2027)
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Stem Cell Transplant
1.4.5 Targeted Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Acute Myeloid Leukemia Market Share by Application (2016-2027)
1.5.2 Hospital
1.5.3 Retails Drug Stores
1.5.4 Ambulatory Care Centers
1.5.5 Oncology Centers
1.5.6 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Acute Myeloid Leukemia Market Size
2.2 Acute Myeloid Leukemia Growth Trends by Regions
2.2.1 Acute Myeloid Leukemia Market Size by Regions (2016-2027)
2.2.2 Acute Myeloid Leukemia Market Share by Regions (2016-2021)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Acute Myeloid Leukemia Market Size by Manufacturers
3.1.1 Global Acute Myeloid Leukemia Revenue by Manufacturers (2016-2021)
3.1.2 Global Acute Myeloid Leukemia Revenue Market Share by Manufacturers (2016-2021)
3.1.3 Global Acute Myeloid Leukemia Market Concentration Ratio (CR5 and HHI)
3.2 Acute Myeloid Leukemia Key Players Head office and Area Served
3.3 Key Players Acute Myeloid Leukemia Product/Solution/Service
3.4 Date of Enter into Acute Myeloid Leukemia Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Acute Myeloid Leukemia Market Size by Type (2016-2021)
4.2 Global Acute Myeloid Leukemia Market Size by Application (2016-2021)

5 United States
5.1 United States Acute Myeloid Leukemia Market Size (2016-2021)
5.2 Acute Myeloid Leukemia Key Players in United States
5.3 United States Acute Myeloid Leukemia Market Size by Type
5.4 United States Acute Myeloid Leukemia Market Size by Application

6 Europe
6.1 Europe Acute Myeloid Leukemia Market Size (2016-2021)
6.2 Acute Myeloid Leukemia Key Players in Europe
6.3 Europe Acute Myeloid Leukemia Market Size by Type
6.4 Europe Acute Myeloid Leukemia Market Size by Application

7 China
7.1 China Acute Myeloid Leukemia Market Size (2016-2021)
7.2 Acute Myeloid Leukemia Key Players in China
7.3 China Acute Myeloid Leukemia Market Size by Type
7.4 China Acute Myeloid Leukemia Market Size by Application

8 Japan
8.1 Japan Acute Myeloid Leukemia Market Size (2016-2021)
8.2 Acute Myeloid Leukemia Key Players in Japan
8.3 Japan Acute Myeloid Leukemia Market Size by Type
8.4 Japan Acute Myeloid Leukemia Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Acute Myeloid Leukemia Market Size (2016-2021)
9.2 Acute Myeloid Leukemia Key Players in Southeast Asia
9.3 Southeast Asia Acute Myeloid Leukemia Market Size by Type
9.4 Southeast Asia Acute Myeloid Leukemia Market Size by Application

10 India
10.1 India Acute Myeloid Leukemia Market Size (2016-2021)
10.2 Acute Myeloid Leukemia Key Players in India
10.3 India Acute Myeloid Leukemia Market Size by Type
10.4 India Acute Myeloid Leukemia Market Size by Application

11 Central & South America
11.1 Central & South America Acute Myeloid Leukemia Market Size (2016-2021)
11.2 Acute Myeloid Leukemia Key Players in Central & South America
11.3 Central & South America Acute Myeloid Leukemia Market Size by Type
11.4 Central & South America Acute Myeloid Leukemia Market Size by Application

12 International Players Profiles
12.1 Celgene Corporation
12.1.1 Celgene Corporation Company Details
12.1.2 Company Description and Business Overview
12.1.3 Acute Myeloid Leukemia Introduction
12.1.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2016-2021)
12.1.5 Celgene Corporation Recent Development
12.2 Cephalon
12.2.1 Cephalon Company Details
12.2.2 Company Description and Business Overview
12.2.3 Acute Myeloid Leukemia Introduction
12.2.4 Cephalon Revenue in Acute Myeloid Leukemia Business (2016-2021)
12.2.5 Cephalon Recent Development
12.3 Clavis Pharma
12.3.1 Clavis Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Acute Myeloid Leukemia Introduction
12.3.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2016-2021)
12.3.5 Clavis Pharma Recent Development
12.4 Eisai
12.4.1 Eisai Company Details
12.4.2 Company Description and Business Overview
12.4.3 Acute Myeloid Leukemia Introduction
12.4.4 Eisai Revenue in Acute Myeloid Leukemia Business (2016-2021)
12.4.5 Eisai Recent Development
12.5 Genzyme Corporation
12.5.1 Genzyme Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Acute Myeloid Leukemia Introduction
12.5.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2016-2021)
12.5.5 Genzyme Corporation Recent Development
12.6 Sunesis Pharmaceuticals
12.6.1 Sunesis Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Acute Myeloid Leukemia Introduction
12.6.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2016-2021)
12.6.5 Sunesis Pharmaceuticals Recent Development
12.7 Abbvie
12.7.1 Abbvie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Acute Myeloid Leukemia Introduction
12.7.4 Abbvie Revenue in Acute Myeloid Leukemia Business (2016-2021)
12.7.5 Abbvie Recent Development
12.8 Astellas Pharma
12.8.1 Astellas Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Acute Myeloid Leukemia Introduction
12.8.4 Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2016-2021)
12.8.5 Astellas Pharma Recent Development
12.9 CTI Biopharma Corp
12.9.1 CTI Biopharma Corp Company Details
12.9.2 Company Description and Business Overview
12.9.3 Acute Myeloid Leukemia Introduction
12.9.4 CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2016-2021)
12.9.5 CTI Biopharma Corp Recent Development

13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures

Table Acute Myeloid Leukemia Key Market Segments
Table Key Players Acute Myeloid Leukemia Covered
Table Global Acute Myeloid Leukemia Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Acute Myeloid Leukemia Market Size Market Share by Type 2016-2027
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Stem Cell Transplant Figures
Table Key Players of Stem Cell Transplant
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figure Others Figures
Table Key Players of Others
Table Global Acute Myeloid Leukemia Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospital Case Studies
Figure Retails Drug Stores Case Studies
Figure Ambulatory Care Centers Case Studies
Figure Oncology Centers Case Studies
Figure Clinics Case Studies
Figure Acute Myeloid Leukemia Report Years Considered
Table Global Acute Myeloid Leukemia Market Size 2016-2027 (Million US$)
Figure Global Acute Myeloid Leukemia Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Acute Myeloid Leukemia Market Size by Regions 2016-2027 (Million US$)
Table Global Acute Myeloid Leukemia Market Size by Regions 2016-2021 (Million US$)
Table Global Acute Myeloid Leukemia Market Share by Regions 2016-2021
Figure Global Acute Myeloid Leukemia Market Share by Regions 2016-2021
Figure Global Acute Myeloid Leukemia Market Share by Regions 2021
Table Market Top Trends
Table Global Acute Myeloid Leukemia Revenue by Manufacturers (2016-2021) (Million US$)
Table Global Acute Myeloid Leukemia Market Share by Manufacturers (2016-2021)
Figure Global Acute Myeloid Leukemia Market Share by Manufacturers in 2021
Table Global Acute Myeloid Leukemia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Acute Myeloid Leukemia Product/Solution/Service
Table Date of Enter into Acute Myeloid Leukemia Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Acute Myeloid Leukemia Market Size by Type (2016-2021) (Million US$)
Table Global Acute Myeloid Leukemia Market Size Share by Type (2016-2021)
Figure Global Acute Myeloid Leukemia Market Size Market Share by Type (2016-2021)
Table Global Acute Myeloid Leukemia Market Size by Application (2016-2021) (Million US$)
Table Global Acute Myeloid Leukemia Market Size Share by Application (2016-2021)
Figure Global Acute Myeloid Leukemia Market Size Market Share by Application (2016-2021)
Figure Global Acute Myeloid Leukemia Revenue Market Share by Application in 2020
Figure United States Acute Myeloid Leukemia Market Size 2016-2021 (Million US$)
Table United States Key Players Acute Myeloid Leukemia Revenue (2020-2021) (Million US$)
Table United States Key Players Acute Myeloid Leukemia Market Share (2020-2021)
Table United States Acute Myeloid Leukemia Market Size by Type (2016-2021) (Million US$)
Table United States Acute Myeloid Leukemia Market Share by Type (2016-2021)
Table United States Acute Myeloid Leukemia Market Size by Application (2016-2021) (Million US$)
Table United States Acute Myeloid Leukemia Market Share by Application (2016-2021)
Figure Europe Acute Myeloid Leukemia Market Size 2016-2021 (Million US$)
Table Europe Key Players Acute Myeloid Leukemia Revenue (2020-2021) (Million US$)
Table Europe Key Players Acute Myeloid Leukemia Market Share (2020-2021)
Table Europe Acute Myeloid Leukemia Market Size by Type (2016-2021) (Million US$)
Table Europe Acute Myeloid Leukemia Market Share by Type (2016-2021)
Table Europe Acute Myeloid Leukemia Market Size by Application (2016-2021) (Million US$)
Table Europe Acute Myeloid Leukemia Market Share by Application (2016-2021)
Figure China Acute Myeloid Leukemia Market Size 2016-2021 (Million US$)
Table China Key Players Acute Myeloid Leukemia Revenue (2020-2021) (Million US$)
Table China Key Players Acute Myeloid Leukemia Market Share (2020-2021)
Table China Acute Myeloid Leukemia Market Size by Type (2016-2021) (Million US$)
Table China Acute Myeloid Leukemia Market Share by Type (2016-2021)
Table China Acute Myeloid Leukemia Market Size by Application (2016-2021) (Million US$)
Table China Acute Myeloid Leukemia Market Share by Application (2016-2021)
Figure Japan Acute Myeloid Leukemia Market Size 2016-2021 (Million US$)
Table Japan Key Players Acute Myeloid Leukemia Revenue (2020-2021) (Million US$)
Table Japan Key Players Acute Myeloid Leukemia Market Share (2020-2021)
Table Japan Acute Myeloid Leukemia Market Size by Type (2016-2021) (Million US$)
Table Japan Acute Myeloid Leukemia Market Share by Type (2016-2021)
Table Japan Acute Myeloid Leukemia Market Size by Application (2016-2021) (Million US$)
Table Japan Acute Myeloid Leukemia Market Share by Application (2016-2021)
Figure Southeast Asia Acute Myeloid Leukemia Market Size 2016-2021 (Million US$)
Table Southeast Asia Key Players Acute Myeloid Leukemia Revenue (2020-2021) (Million US$)
Table Southeast Asia Key Players Acute Myeloid Leukemia Market Share (2020-2021)
Table Southeast Asia Acute Myeloid Leukemia Market Size by Type (2016-2021) (Million US$)
Table Southeast Asia Acute Myeloid Leukemia Market Share by Type (2016-2021)
Table Southeast Asia Acute Myeloid Leukemia Market Size by Application (2016-2021) (Million US$)
Table Southeast Asia Acute Myeloid Leukemia Market Share by Application (2016-2021)
Figure India Acute Myeloid Leukemia Market Size 2016-2021 (Million US$)
Table India Key Players Acute Myeloid Leukemia Revenue (2020-2021) (Million US$)
Table India Key Players Acute Myeloid Leukemia Market Share (2020-2021)
Table India Acute Myeloid Leukemia Market Size by Type (2016-2021) (Million US$)
Table India Acute Myeloid Leukemia Market Share by Type (2016-2021)
Table India Acute Myeloid Leukemia Market Size by Application (2016-2021) (Million US$)
Table India Acute Myeloid Leukemia Market Share by Application (2016-2021)
Figure Central & South America Acute Myeloid Leukemia Market Size 2016-2021 (Million US$)
Table Central & South America Key Players Acute Myeloid Leukemia Revenue (2020-2021) (Million US$)
Table Central & South America Key Players Acute Myeloid Leukemia Market Share (2020-2021)
Table Central & South America Acute Myeloid Leukemia Market Size by Type (2016-2021) (Million US$)
Table Central & South America Acute Myeloid Leukemia Market Share by Type (2016-2021)
Table Central & South America Acute Myeloid Leukemia Market Size by Application (2016-2021) (Million US$)
Table Central & South America Acute Myeloid Leukemia Market Share by Application (2016-2021)
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2016-2021) (Million US$)
Figure Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Table Celgene Corporation Recent Development
Table Cephalon Company Details
Table Cephalon Revenue in Acute Myeloid Leukemia Business (2016-2021)(Million US$)
Figure Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Table Cephalon Recent Development
Table Clavis Pharma Company Details
Table Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2016-2021)(Million US$)
Figure Clavis Pharma Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Table Clavis Pharma Recent Development
Table Eisai Company Details
Table Eisai Revenue in Acute Myeloid Leukemia Business (2016-2021)(Million US$)
Figure Eisai Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Table Eisai Recent Development
Table Genzyme Corporation Company Details
Table Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2016-2021)(Million US$)
Figure Genzyme Corporation Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Table Genzyme Corporation Recent Development
Table Sunesis Pharmaceuticals Company Details
Table Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2016-2021)(Million US$)
Figure Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Table Sunesis Pharmaceuticals Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Acute Myeloid Leukemia Business (2016-2021)(Million US$)
Figure Abbvie Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Table Abbvie Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2016-2021)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Table Astellas Pharma Recent Development
Table CTI Biopharma Corp Company Details
Table CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2016-2021)(Million US$)
Figure CTI Biopharma Corp Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Table CTI Biopharma Corp Recent Development
Table Global Acute Myeloid Leukemia Market Size by Regions (Million US$) 2021-2027
Figure Global Acute Myeloid Leukemia Market Size Share by Regions (2021-2027)
Figure Global Acute Myeloid Leukemia Market Size Share by Regions in 2025
Figure United States Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure Europe Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure China Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure Japan Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure India Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Table Global Acute Myeloid Leukemia Market Size by Product (2021-2027) (Million US$)
Figure Global Acute Myeloid Leukemia Market Size by Product (2021-2027)
Figure Global Acute Myeloid Leukemia Market Size by Product in 2025
Table Global Acute Myeloid Leukemia Market Size by Application (2021-2027) (Million US$)
Figure Global Acute Myeloid Leukemia Market Size by Application (2021-2027)
Figure Global Acute Myeloid Leukemia Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Research Allied Copyright © 2022 .